Latest research
Latest corporate research
Latest tax enhanced reviews
Subscribe now
What we do
Investment research services
Tax enhanced research services
Bespoke consulting services
About Hardman & Co.
Case Studies
Our team
News & events
Contact us
Twitter icon
Created with Sketch.
×
Latest corporate investment research
Detailed company analysis created specifically for investors
Latest tax enhanced research
Product reports for investors and advisors
Subscribe now
Receive our latest research as soon as it is published
Investment Research & Analysis
Detailed company analysis created for specifically for investors
Tax Enhanced Services
Product reports for investors and advisors
Bespoke Services
Services for clients with specific needs
About Hardman & Co.
We are the longest-established commissioned research provider. Read our story
Case Studies
We help a wide range of clients with different needs. Read what they say about us
Our Team
Meet the Hardman & Co team members
EVENT -
Hardman & Co November Investor Forum – Registration open now
Latest Update
Our research can still be accessed for free under MIFID II.
Find out more >
All sectors
Agriculture
Building & Construction
Consumer
Financials
Industrial
Investment Companies
Life Sciences
Media
Mining
Oil & Gas
Property
Renewables
Services
Technology
Utilities
list companies
Allergy Therapeutics plc
Life Sciences
Disruptive peanut allergy vaccine
By
Dr Martin Hall
13 Feb 2017
Alliance Pharma Plc
Life Sciences
Potential of Diclectin
By
Dr Martin Hall
25 Jan 2017
Stay up-to-date with the latest research
Sign up to our newsletter
City of London Investment Group
Financials
Q2 statement shows robust profitability
By
Dr Brian Moretta
24 Jan 2017
Allergy Therapeutics plc
Life Sciences
Investment driving market share gains
By
Dr Martin Hall
20 Jan 2017
Diurnal Group Plc
Life Sciences
Infacort® – On track to market
By
Dr Martin Hall
19 Jan 2017
City of London Investment Group
Financials
Swings and roundabouts
By
Dr Brian Moretta
06 Jan 2017
Prev
1
...
12
13
14